⌘K

Login Start Free

Home/Filings/4/0001127602-17-021955

4//SEC Filing

Edge Therapeutics, Inc. 4

Accession 0001127602-17-021955

$PDSBCIK 0001472091operating

View on SEC.gov Company Profile

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 2:26 PM ET

Size

4.8 KB

Accession

0001127602-17-021955

Insider Transaction Report

Form 4

Period: 2017-06-20

Edge Therapeutics, Inc.EDGE

Director

Transactions

Award
Stock Option (right To Purchase)
2017-06-20$10.15/sh+15,000$152,250→ 15,000 total
Exercise: $10.15From: 2018-06-20Exp: 2027-06-20→ Common Stock (15,000 underlying)

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Edge Therapeutics, Inc.

CIK 0001472091

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001472091

Filing Metadata

Form type: 4
Filed: Jun 20, 8:00 PM ET
Accepted: Jun 21, 2:26 PM ET
Size: 4.8 KB

View on SEC.gov